These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery. Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372 [TBL] [Abstract][Full Text] [Related]
28. Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA. Blakney AK; McKay PF; Yus BI; Aldon Y; Shattock RJ Gene Ther; 2019 Sep; 26(9):363-372. PubMed ID: 31300730 [TBL] [Abstract][Full Text] [Related]
29. Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles. Kulkarni JA; Thomson SB; Zaifman J; Leung J; Wagner PK; Hill A; Tam YYC; Cullis PR; Petkau TL; Leavitt BR Nanoscale; 2020 Dec; 12(47):23959-23966. PubMed ID: 33241838 [TBL] [Abstract][Full Text] [Related]
30. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388 [TBL] [Abstract][Full Text] [Related]
31. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Cheng X; Lee RJ Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977 [TBL] [Abstract][Full Text] [Related]
32. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA. Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050 [TBL] [Abstract][Full Text] [Related]
33. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311 [TBL] [Abstract][Full Text] [Related]
34. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers. Hood RR; Shao C; Omiatek DM; Vreeland WN; DeVoe DL Pharm Res; 2013 Jun; 30(6):1597-607. PubMed ID: 23386106 [TBL] [Abstract][Full Text] [Related]
35. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics. Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715 [TBL] [Abstract][Full Text] [Related]
36. Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines. Loughney JW; Minsker K; Ha S; Rustandi RR Electrophoresis; 2019 Sep; 40(18-19):2602-2609. PubMed ID: 31218707 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel cholesterol-based ionizable lipids for mRNA delivery. Qian R; Ullah A; Cui J; Cai X; Cao J; Wu L; Shen S Colloids Surf B Biointerfaces; 2024 Aug; 240():113980. PubMed ID: 38781845 [TBL] [Abstract][Full Text] [Related]
38. Evolution of the structure of lipid nanoparticles for nucleic acid delivery: From in situ studies of formulation to colloidal stability. Gilbert J; Sebastiani F; Arteta MY; Terry A; Fornell A; Russell R; Mahmoudi N; Nylander T J Colloid Interface Sci; 2024 Apr; 660():66-76. PubMed ID: 38241872 [TBL] [Abstract][Full Text] [Related]